Bioventus Inc.
US ˙ NasdaqGS ˙ US09075A1088

SecurityBVS / Bioventus Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership258,801 shares
Latest Disclosed Value $ 2,362,857
Morgan Stanley reports 14.38% decrease in ownership of BVS / Bioventus Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 258,801 shares of Bioventus Inc. (US:BVS) valued at $2,362,853 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 302,258 shares of Bioventus Inc.. This represents a change in shares of -14.38% during the quarter. The current value of the position is $2,251,569 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOVENTUS COM CL A 09075A108 258,801 -43,457 -14.38 2,363 5.07 0.0001
2026-05-27 2025-12-31 13F/A-1 BIOVENTUS COM CL A 09075A108 302,258 58,509 24.00 2,249 37.91 0.0001
2026-02-13 2025-12-31 13F BIOVENTUS COM CL A 09075A108 302,258 58,509 2,249 0.0001
2026-05-27 2025-09-30 13F/A-1 BIOVENTUS COM CL A 09075A108 243,749 -409,162 -62.67 1,631 -62.29 0.0001
2025-11-14 2025-09-30 13F BIOVENTUS COM CL A 09075A108 243,749 -409,162 1,631 0.0001
2025-08-15 2025-06-30 13F BIOVENTUS COM CL A 09075A108 652,911 159,793 32.40 4,322 -4.21 0.0003
2025-05-15 2025-03-31 13F BIOVENTUS COM CL A 09075A108 493,118 -149,484 -23.26 4,512 -33.13 0.0003
2025-05-15 2024-12-31 13F/A-1 BIOVENTUS COM CL A 09075A108 642,602 -365,074 -36.23 6,747 -43.97 0.0005
2025-02-14 2024-12-31 13F BIOVENTUS COM CL A 09075A108 642,602 -365,074 6,747 0.0005
2025-05-14 2024-09-30 13F/A-2 BIOVENTUS COM CL A 09075A108 1,007,676 484,235 92.51 12,042 300.17 0.0009
2025-02-14 2024-09-30 13F/A-1 BIOVENTUS COM CL A 09075A108 1,007,676 484,235 12,042 0.0009
2024-11-14 2024-09-30 13F BIOVENTUS COM CL A 09075A108 1,007,676 484,235 12,042 0.0001
2025-05-14 2024-06-30 13F/A-2 BIOVENTUS COM CL A 09075A108 523,441 78,394 17.61 3,010 30.03 0.0002
2024-10-17 2024-06-30 13F/A-1 BIOVENTUS COM CL A 09075A108 523,441 78,394 3,010 0.0002
2024-08-14 2024-06-30 13F BIOVENTUS COM CL A 09075A108 523,441 78,394 3,010 0.0002
2024-10-17 2024-03-31 13F/A-2 BIOVENTUS COM CL A 09075A108 445,047 251,518 129.96 2,314 127.09 0.0002
2024-08-16 2024-03-31 13F/A-1 BIOVENTUS COM CL A 09075A108 445,047 251,518 2,314 0.0000
2024-05-15 2024-03-31 13F BIOVENTUS COM CL A 09075A108 445,047 251,518 2,314 0.0002
2024-08-16 2023-12-31 13F/A-1 BIOVENTUS COM CL A 09075A108 193,529 182,875 1,716.49 1,020 2,811.43 0.0001
2024-02-13 2023-12-31 13F BIOVENTUS COM CL A 09075A108 193,529 182,875 1,020 0.0001
2023-11-15 2023-09-30 13F BIOVENTUS COM CL A 09075A108 10,654 -8,061 -43.07 35 -35.19 0.0000
2023-08-14 2023-06-30 13F BIOVENTUS COM CL A 09075A108 18,715 -51,248 -73.25 54 -27.03 0.0000
2023-05-15 2023-03-31 13F BIOVENTUS COM CL A 09075A108 69,963 -47,129 -40.25 75 -75.74 0.0000
2023-02-14 2022-12-31 13F BIOVENTUS COM CL A 09075A108 117,092 78,448 203.00 306 12.13 0.0000
2022-11-14 2022-09-30 13F BIOVENTUS COM CL A 09075A108 38,644 28 0.07 272 3.82 0.0000
2022-10-27 2022-06-30 13F/A-1 BIOVENTUS COM CL A 09075A108 38,616 7,235 23.06 262 -40.86 0.0000
2022-08-15 2022-06-30 13F BIOVENTUS COM CL A 09075A108 38,616 7,235 262 0.0000
2022-10-27 2022-03-31 13F/A-1 BIOVENTUS COM CL A 09075A108 31,381 -27,039 -46.28 443 -47.70 0.0001
2022-05-13 2022-03-31 13F BIOVENTUS COM CL A 09075A108 31,381 -27,039 443 0.0001
2022-02-14 2021-12-31 13F BIOVENTUS COM CL A 09075A108 58,420 52,170 834.72 847 862.50 0.0001
2021-11-15 2021-09-30 13F BIOVENTUS COM CL A 09075A108 6,250 -12,171 -66.07 88 -72.84 0.0000
2021-08-23 2021-06-30 13F/A-1 BIOVENTUS COM CL A 09075A108 18,421 17,766 2,712.37 324 3,140.00 0.0000
2021-08-16 2021-06-30 13F BIOVENTUS COM CL A 09075A108 18,421 17,766 324 0.0000
2021-05-17 2021-03-31 13F BIOVENTUS COM CL A 09075A108 655 655 10 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.